Abstract
Rhodium(I) carbonyl complexes of the form [RhI(N,O-ScBa)(CO)(PR3)] (R = Ph or Cy), with N,O-ScBaH a mono anionic bidentate Schiff base ligand, 2-(cyclopentyliminomethyl)-5-methylphenol (5-Me-Sal-CyPH), and bearing different phosphine ligands on Rh(I), are reported. N,O-ScBaH was also varied to be 2-(cyclohexyliminomethyl)phenol (Sal-CyH) and 2-(isopropyliminomethyl)-5-methylphenol (5-Me-Sal-IPropH) to investigate the effects of different substituent groups on the periphery of the Schiff bases on metal center reactivity. The structural characterization of two sample complexes is described and an extensive spectroscopic kinetic-mechanistic study utilizing UV/vis, infrared and 31P NMR spectroscopy of the iodomethane oxidative addition is presented. Iodomethane oxidative addition led exclusively to RhIII-alkyl complexes as final products, while an associative activation is inferred from the large negative ΔS≠ value. The relative reactivity of the [RhI(N,O-ScBa)(CO)(PR3)] complexes when stepwise varying PR3 (PPh3, PPh2Cy, PPhCy2 and PCy3) as tertiary phosphine ligands follow a surprising similar reactivity relationship as observed for a range of isostructural [RhI(X,O-Bid)(CO)(PR3)] complexes, with X = O, N or S in corresponding oxinate, acetylacetonate and thioureate mono anionic X,O-Bid ligands. This suggests systematic and responsive dynamic behavior of the PR3 ligands, independent of the bidentate chelate at the Rh(I) metal center. A variation of more than two orders-of-magnitude in reactivity was observed.
Graphical Abstract
![](/cms/asset/b926c301-c57d-4138-b72f-a93648200e21/gcoo_a_1809657_uf0001_c.jpg)
Acknowledgements
Financial assistance from the University of the Free State and the SA NRF is gratefully acknowledged. Opinions, findings, conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the SA NRF. Drs. D.V. Kama and O.T. Alexander are acknowledged for the single crystal data collections and assistance with solving the structures.
Disclosure statement
The authors declare no conflict of interest.